Stock Price
1.03
Daily Change
0.01 0.98%
Monthly
31.29%
Yearly
-44.32%
Q2 Forecast
1.00

RedHill Biopharma reported $18.38M in Assets for its fiscal quarter ending in June of 2025.





Assets Change Date
Cara Therapeutics USD 32.07M 6.95M Dec/2025
Clal Biotechnology ILS 158.39M 24.3M Dec/2023
Compugen USD 156.57M 58.73M Dec/2025
Cronos Group USD 1.17B 25.03M Mar/2026
RedHill Biopharma USD 18.38M 332K Jun/2025